Effect of antenatal spiramycin treatment on the frequency of retinochoroiditis due to congenital toxoplasmosis in a Colombian cohort

Biomédica : revista del Instituto Nacional de Salud
Liliana María ZuluagaJorge Hernando Donado

Abstract

Gestational toxoplasmosis is frequent and severe. There is still debate about the benefits of treatment against ocular manifestations in the newborn. Spiramycin treatment is used for this purpose, unfortunately prenatal diagnosis is sometimes delayed and pregnant women are not treated. To describe the relationship between treatment with spiramycin during pregnancy in mothers with gestational toxoplasmosis and development of ocular toxoplasmosis in newborns. We conducted a descriptive study of a case series. We evaluated a prospective cohort of patients diagnosed with gestational toxoplasmosis during three years at the Retinology Service at the Clínica Universitaria Bolivariana in Medellín. Gestational toxoplasmosis was found in 23 mothers; 15 (65%) were treated during pregnancy with 3 g per day of spiramycin, eight (35%) patients were untreated. In the treated group just one newborn developed ocular toxoplasmosis (6.6%), in contrast with five (62.5%) of the eight patients who did not receive treatment. These results suggest that pregnancy treatment reduces the relative risk of ocular toxoplasmosis in the newborn by 96% (95% CI: 33 - 100%). Only two (14%) of the patients who were evaluated, had nervous system involvement related...Continue Reading

References

Dec 4, 2003·American Journal of Ophthalmology·Gary N Holland
Jul 25, 2006·Archives of Disease in Childhood·R Gilbert, C Dezateux
Dec 23, 2006·Archives of Disease in Childhood·J E Gomez-MarinJ C Castaño
Jan 16, 2007·Lancet·UNKNOWN SYROCOT (Systematic Review on Congenital Toxoplasmosis) study groupRuth Gilbert
Jan 30, 2007·American Journal of Ophthalmology·Alejandra de-la-TorreJorge Enrique Gómez-Marín
Jul 16, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jose G Montoya, Jack S Remington
Aug 22, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P ValentiniO Ranno
Apr 9, 2010·International Ophthalmology Clinics·J Fernando ArevaloJuan V Espinoza
Oct 23, 2010·PLoS Medicine·Mario Cortina-BorjaUNKNOWN European Multicentre Study on Congenital Toxoplasmosis (EMSCOT)
Jun 10, 2011·PLoS Neglected Tropical Diseases·Jorge Enrique Gómez-MarinGiovanny Castaño
Mar 14, 2012·Ocular Immunology and Inflammation·Eskild PetersenMiles Stanford
Sep 18, 2012·Gynécologie, obstétrique & fertilité·L Mandelbrot
Jan 25, 2013·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Caroline Paquet, Mark H Yudin
Jan 29, 2013·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·F Baquero-ArtigaoUNKNOWN Grupo de Trabajo de Infección Congénita y Perinatal de la Sociedad Española de Infectología Pediátrica (SEIP)
Apr 30, 2013·Handbook of Clinical Neurology·François Kieffer, Martine Wallon
Oct 18, 2013·Ocular Immunology and Inflammation·Aize Kijlstra, Eskild Petersen
Jan 21, 2014·BMC Infectious Diseases·Mariza M AvelinoAna M Castro
Feb 19, 2014·Pediatrics·Martine WallonChristine Binquet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.